Genetic divergence and dispersal of yellow fever virus, Brazil

Emerging Infectious Diseases

Volumn 10, Issue 9, 2004, Pages 1578-1584

  Vasconcelos, Pedro F C ^a   Bryant, Juliet E ^b   Travassos Da Rosa, Amelia P A ^b   Tesh, Robert B ^b   Rodrigues, Sueli G ^a   Barrett, Alan D T ^b  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; VIRUS VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; DIAGNOSTIC ERROR; FATALITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; HUMAN; MIGRATION; NONHUMAN; PHYLOGENY; VIROLOGY; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

EID: 4444302952     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1009.040197     Document Type: Article

References (39)

1. Monath TP. Epidemiology of yellow fever: current status and speculations on future trends. In: Saluzzo JF, Dodet B, editors. Amsterdam: Elsevier; 1997. p. 143-65.
2. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K. Yellow fever: a decade of reemergence. JAMA. 1996;276:1157-62.
3. Vainio J, Cutts F. Yellow fever. Global programme for vaccines and immunization. WHO/EPI/GEN/98.11. Geneva: World Health Organization; 1998.
4. Vasconcelos PFC, Costa ZG, Travassos da Rosa ES, Luna E, Rodrigues SG, Barros VLRS, et al. Epidemic of jungle yellow fever in Brazil, 2000: implications of climatic alterations in disease spread. J Med Virol. 2001;65:598-604.
5. Filippis AM, Schatzmayr HG, Nicolai C, Baran M, Miagostovich MP, Sequeira PC, et al. Jungle yellow fever, Rio de Janeiro. Emerg Infect Dis. 2001;7:484-5.
6. Dégallier N, Travassos da Rosa AP, Hervé JP, Travassos da Rosa JFS, Vasconcelos PFC, Silva CJM, et al. A comparative study of yellow fever in Africa and South America. J Braz Assoc Advanc Sci. 1992;44:143-51.
7. Mondet B, Travassos da Rosa APA, Vasconcelos PFC. The risk of urban yellow fever outbreaks in Brazil by dengue vectors Aedes aegypti and Aedes albopictus. Bull Soc Pathol Exot. 1996;89:107-13.
8. Fundação Nacional de Saúde (FUNASA). Distribuição de casos confirmados de febre amarela notificados por unidade federativa no Brasil, 1981-2002. Brasília: Ministério da Saúde; 2003.
9. Massad E, Burattini MN, Coutinho FA, Lopez LF. Dengue and the risk of urban yellow fever reintroduction in Sao Paulo State, Brazil. Rev Saude Publica. 2003;37:477-84.
10. Figueiredo LT. The Brazilian flaviviruses. Microbes Infect. 2000;2:1643-9.
11. Beaty BJ, Calisher CH, Shope RE. Arboviruses. In: Lennette EH, Schmidt NJ, editors. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 6th ed. Washington: American Public Health Association; 1989. p. 797-855.
12. Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phytogeny of the genus Flavivirus. J Virol. 1998;72:73-83.
13. Wang E, Weaver SC, Shope RE, Tesh RB, Watts DM, Barren AD. Genetic variation in yellow fever virus: duplication in the 3′ noncoding region of strains from Africa. Virology. 1996;225:274-81.
14. Bryant JE, Barrett ADT. Comparative phytogenies of yellow fever isolates from Peru and Brazil. FEMS Immunol Med Microbiol. 2003;39:103-18.
15. Deubel V, Digoutte JP, Monath TP, Girard M. Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol. 1986;67:209-13.
16. Swofford DL. PAUP*. Phylogenetic analysis using parsimony (* and other methods). Sunderland (MA): Sinauer Associates; 1998.
17. Hahn CS, Dalrymple JM, Strauss JH, Rice CM. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci USA. 1987;84:2019-23.
18. Duarte dos Santos CN, Post PR, Carvalho R, Ferreira II, Rice CM, Galler R. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. Virus Res. 1995;35:35-41.
19. Vasconcelos PFC, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VLRS, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases [errata in Lancet. 2001;358:336; Lancet. 2001;358:1018]. Lancet. 2001;358:91-7.
20. Vasconcelos PFC, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VLRS, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases [errata in Lancet. 2001;358:336; Lancet. 2001;358:1018]. Lancet. 2001;358:91-7.
21. Vasconcelos PFC, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VLRS, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases [errata in Lancet. 2001;358:336; Lancet. 2001;358:1018]. Lancet. 2001;358:91-7.
22. Mutebi JP, Wang H, Li L, Bryant JE, Barren AD. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J Virol. 2001;75:6999-7008.
23. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2 angstrom resolution. Nature. 1995;375:291-8.
24. Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol. 2001;75:4268-75.
25. Fitzgeorge R, Bradish CJ. The in vitro differentiation of strains of yellow fever virus in mice. J Gen Virol. 1980;46:1-13.
26. Monath TP. Milestones in the conquest of yellow fever. In: Koprowski H, Oldstone MBA, editors. Microbes and man - then and now. Bloomington (IN): Medi-Ed Press; 1996. p. 95-111.
27. Heraud JM, Hommel D, Hulin A, Deubel V, Poveda JD, Sarthon JL, et al. First case of yellow fever in French Guiana since 1902. Emerg Infect Dis. 1999;5:429-32.
28. Soper FL. Ventures in world health. Scientific publication no. 355. Washington: Pan American Health Organization; 1977.
29. Monath TP. Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last 40 years and prospects for the future. Am J Trop Med Hyg. 1991;45:1-43.
30. Pinheiro FP, Travassos da Rosa APA, Moraes MAP, Almeida Neto JC, Camargo S, Filgueiras JP. An epidemic of yellow fever in central Brazil, 1972-1973. I. Epidemiological studies. Am J Trop Med Hyg. 1978;27:125-32.
31. Chippaux A, Deubel V, Moreau JP, Reynes JM. Current situation of yellow fever in Latin America. Bull Soc Pathol Exot. 1993;86:460-4.
32. Kiple KF, Cooper DB. Yellow fever. In: Kiple KF, Graham RR, editors. Cambridge: Cambridge University Press; 1993. p. 1100-7.
33. Monath TP. Yellow fever. In: Monath TP, editor. The arboviruses - epidemiology and ecology. Vol. 5. Boca Raton (FL): CRC Press; 1989. p. 139-231.
34. Vasconcelos PFC, Travassos da Rosa APA, Pinheiro FP, Rodrigues SG, Travassos da Rosa ES, Cruz ACR, et al. Aedes aegypti, dengue, and re-urbanization of yellow fever in Brazil and other South American countries: past and present situation and future perspectives. Dengue Bull. 1999;23:55-66.
35. Vasconcelos PFC, Rodrigues SG, Degallier N, Moraes MAP, Travassos da Rosa JFS, Travassos da Rosa ES, et al. Epidemic of sylvatic yellow fever in southeast region of Maranhão State, Brazil, 1993-1994. Epidemiological and entomological findings. Am J Trop Med Hyg. 1997;57:132-7.
36. Vasconcelos PFC, Travassos da Rosa APA, Rodrigues SG, Travassos da Rosa ES, Montiero HÃO, Cruz ACR, et al. Yellow fever in Para State, Amazon region of Brazil, 1998-1999. Entomological and epidemiological findings. Emerg Infect Dis. 2001;7:565-9.
37. Saeed MF, Wang H, Nunes M, Vasconcelos PFC, Weaver SC, Shope RE, et al. Nucleotide sequences and phytogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol. 2000;81:743-8.
38. Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet. 2001;358:121-2.
39. Martin M, Tsai TF, Cropp B, Chang GJJ, Holmes DA, Tseng J, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet. 2001;358:98-104.